Amylyx Pharmaceuticals, Inc. (AMLX) Insider Trading

Over the last 3 months, AMLX insiders made 1 open-market buy and 0 sales, a net purchase of $51K (SEC Form 4). Over the last 6 months, 147 institutions increased and 100 reduced their position (13F).

Insider Activity

Sentiment
100/100
Buys (3m)
1
Sells (3m)
0
Net (3m)
$51.3K
Insiders buyingFirst buy in 2 quarters
Insider trades by month Buys Sells
Oct
Dec
Jan
Feb
Mar
May
Context3-month price +1.5%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 26, 2026Firestone KarendirectorBuy3,800$13.51
Mar 9, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerGrant248,865
Mar 9, 2026Bedrosian Camille Lofficer: Chief Medical OfficerGrant143,985$14.10
Mar 9, 2026Bedrosian Camille Lofficer: Chief Medical OfficerGrant95,990
Mar 9, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerGrant373,295$14.10
Mar 9, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerGrant248,865
Mar 9, 2026FRATES JAMES Mofficer: Chief Financial OfficerGrant143,985$14.10
Mar 9, 2026FRATES JAMES Mofficer: Chief Financial OfficerGrant95,990
Mar 9, 2026Mazzariello Ginaofficer: Chief Legal OfficerGrant111,990$14.10
Mar 9, 2026Mazzariello Ginaofficer: Chief Legal OfficerGrant74,660
Mar 9, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerGrant373,295$14.10
Mar 4, 2026Mazzariello Ginaofficer: Chief Legal OfficerSell6,844$14.52
Mar 4, 2026Bedrosian Camille Lofficer: Chief Medical OfficerSell6,461$14.58
Mar 4, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerSell29,282$14.47
Mar 4, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerSell29,282$14.48
Mar 4, 2026FRATES JAMES Mofficer: Chief Financial OfficerSell7,909$14.52
Feb 25, 2026Mazzariello Ginaofficer: Chief Legal OfficerSell3,419$14.14
Feb 4, 2026Mazzariello Ginaofficer: Chief Legal OfficerSell3,448$14.65
Feb 4, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerSell15,500$14.68
Feb 4, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerSell15,500$14.69
Feb 4, 2026FRATES JAMES Mofficer: Chief Financial OfficerSell3,557$14.65
Jan 20, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerSell1,995$13.89
Jan 20, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerOption2,818$7.57
Jan 20, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerSell1,974$13.83
Jan 20, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerSell136,193$13.59
Jan 20, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerOption197,153$7.57
Jan 20, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerOption2,847$7.57
Jan 20, 2026Klee Justin B.director, officer: Co-Chief Executive OfficerSell136,193$13.58
Jan 20, 2026Cohen Joshua Bdirector, officer: Co-Chief Executive OfficerOption197,182$7.57
Jan 8, 2026FRATES JAMES Mofficer: Chief Financial OfficerSell3,326$11.11

Source: AMLX SEC Form 4 filings, latest May 26, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their AMLX positions over the last 6 months (SEC Form 13F).

Increased
147
New positions
62
Reduced
100
Sold out
62
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased16.6MMay 15, 2026
PERCEPTIVE ADVISORS LLCIncreased16.6MMay 29, 2026
FMR LLCIncreased16.5MFeb 17, 2026
BLACKROCK, INC.Increased9.1MFeb 12, 2026
BLACKROCK, INC.Reduced8.8MMay 13, 2026
PERCEPTIVE ADVISORS LLCReduced8.3MFeb 17, 2026
TCG CROSSOVER MANAGEMENT, LLCUnchanged6.2MFeb 17, 2026
TCG CROSSOVER MANAGEMENT, LLCUnchanged6.2MMay 15, 2026
VANGUARD GROUP INCIncreased5.8MJan 29, 2026
COMMODORE CAPITAL LPUnchanged5.7MMay 15, 2026
COMMODORE CAPITAL LPIncreased5.7MFeb 17, 2026
JANUS HENDERSON GROUP PLCIncreased5.0MMay 18, 2026
SATURN V CAPITAL MANAGEMENT LLCReduced4.5MFeb 17, 2026
JANUS HENDERSON GROUP PLCIncreased4.5MFeb 17, 2026
SATURN V CAPITAL MANAGEMENT LLCReduced4.3MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.